… may be a plausible treatment option where activated immune cells after exposure to a … using
dendritic cells (DCs) as the antigen presenting cells (APCs). This type of treatment is based …

… Indeed, exosomes isolated from human blood were shown to induce CD4 + T cell apoptosis
… the cells (eg reticulocytes, dendritic cells, B cells, T cells, mast cells, platelets, epithelial cells…

… In this therapeutic method, antigen-presenting autologous dendritic cells was obtained
from the patient by the leukapheresis procedure, then cells was incubated with fusion protein …

Purpose: The objectives of this study were to assess the toxicity and immunologicalresponse
induced by the intradermal (id) administration of tumor lysate-pulsed dendritic cells (DCs). …

… dendritic cells that lack the ability to induce T lymphocyte activation to dendritic cells that …
for modulating dendritic cell function in the treatment of inflammatory disease conditions. …

… , different work groups have tried to utilize dendritic cells (DC) as a treatment tool for patients
with AML [16]. DC are major antigen-presenting cells (APC) that internalize and process …

… < 1% of all cells, known as dendritic cells (DCs). Dendritic cells, originally identified by …
of antigenic peptides and proteins presented to T cells and B cells, and they are now widely …

… Dendritic cell (DC) immunotherapy has shown significant promise in animal studies as a
potential treatment for cancer. Its application in the clinic depends on the results of human trials. …

… Dendritic cells (DCs) are the most potent antigen-presenting cells, and tumor antigen-… of
action with great potential for the systemic treatment of cancers. However, clinical trials have …

… to the immune system are dendritic cells. Understanding of the … phase clinical trials of dendritic
cells for the treatment of cancer. … This paper reviews the biology of dendritic cells and their …